$1.94
0.147.78%
At close: May 11, 5:00 PM EST
$1.92
-0.02-1.03%
After Hours: 7:19 PM EST
Palisade Bio Inc Earnings Estimates
PALINASDAQ
Palisade Bio Earnings Estimates, EPS & Revenue | NASDAQ:PALI
Palisade Bio (PALI) is scheduled to report Q1 earnings on May 22, 2026. Analysts estimate EPS of $-0.04 and quarterly revenue of N/A.
In the most recent quarter (Q4), Palisade Bio reported EPS of $1.08, beating estimates of $-0.04 by 28.00%. Revenue came in at $0.00, meeting the estimate of $0.00 by 0.00%.
Over the last 4 quarters, Palisade Bio has averaged an EPS surprise of 7.21% and a revenue surprise of 0.00%.
Earnings Date
May 22
EPS Estimate
$-0.040
Quarterly Revenue Estimate
–
Annual Revenue
(as of Dec 31)
(as of Dec 31)
–
Palisade Bio Earnings History
Analyze the earnings history of Palisade Bio using advanced sorting and filters.
Loading calendar...
Palisade Bio (PALI) Earnings Per Share
The chart below shows Palisade Bio's reported EPS compared to analyst estimates over recent quarters.
Palisade Bio (PALI) Revenue
The chart below shows Palisade Bio's reported revenue compared to analyst estimates over recent quarters.
FAQ
When is Palisade Bio (NASDAQ:PALI) reporting earnings?
Palisade Bio (PALI) is scheduled to report earnings on August 10, 2026. The last reported earnings were for reported on March 20, 2026 for Q4.
What were the latest earnings per share (EPS) for Palisade Bio (NASDAQ:PALI)?
The Actual EPS was $1.08, which beat the estimate of $-0.04.
What were Palisade Bio’s (NASDAQ:PALI) revenues?
The Actual Revenue was $0.00, which hit the estimate of $0.00.
